Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Armadillo repeat containing 8 pseudogene 1 (ARMC8P1) is a non-protein-coding segment of DNA classified as a pseudogene, showing high sequence homology to the functional ARMC8 gene but predicted to lack protein-coding ability due to genetic disablements such as frameshifts or premature stop codons[2]. Pseudogenes like ARMC8P1 can be transcribed and sometimes function as regulators of their parental coding genes through RNA-based mechanisms, such as acting as microRNA decoys or influencing mRNA stability, but there is no evidence ARMC8P1 has any such specific biological function or disease role[1][3]. ARMC8P1 is not a therapeutic target, receptor, enzyme, or druggable molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Armadillo repeat containing 8 pseudogene 1 (ARMC8P1).